ApprovalTrail

Medical device licence · 110238 · Class 2

HEMOSTASYL

No longer licensed: cancelled

Licence status Cancelled; first licensed October 30, 2023; ended March 21, 2025. It is in Health Canada’s archive of licences no longer in force.
Licence number
110238
Licence holder
Acteon ManufacturingMerignac, France
Risk class
Class II (low to moderate risk)
Licence type
System
First licensed
October 30, 2023
Ended
March 21, 2025
Devices covered
3

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • HEMOSTASYL (CANULES)
  • HEMOSTASYL (COFFRET)
  • HEMOSTASYL (SERINGUES)

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.